OTC Pharmaceuticals in Australia

Introduction

OTC Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Australia otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

• The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2010 annual average exchange rates.
• The Australian OTC pharmaceuticals market generated total revenues of $3.5 billion in 2010, representing a compound annual growth rate (CAGR) of 4.9% for the period spanning 2006-2010.
• Traditional medicines sales proved the most lucrative for the Australian OTC pharmaceuticals market in 2010, generating total revenues of $1.4 billion, equivalent to 41.6% of the market's overall value.
• The performance of the market is forecast to decelerate, with an anticipated CAGR of 3.9% for the five-year period 2010-2015, which is expected to lead the market to a value of $4.2 billion by the end of 2015.

Features

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in Australia
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in Australia
• Leading company profiles reveal details of key otc pharmaceuticals market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the Australia otc pharmaceuticals market with five year forecasts by both value and volume
• Macroeconomic indicators provide insight into general trends within the Australia economy

Key Questions Answered

• What was the size of the Australia otc pharmaceuticals market by value in 2010?
• What will be the size of the Australia otc pharmaceuticals market in 2015?
• What factors are affecting the strength of competition in the Australia otc pharmaceuticals market?
• How has the market performed over the last five years?
• Who are the top competitiors in Australia's otc pharmaceuticals market?

Contents

EXECUTIVE SUMMARY

MARKET OVERVIEW

Market definition
Market analysis

MARKET DATA

Market value

MARKET SEGMENTATION

Category segmentation
Geography segmentation
Market share
Market distribution

MARKET OUTLOOK

Market value forecast

FIVE FORCES ANALYSIS

Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry

LEADING COMPANIES

Cerebos Pacific Limited
Reckitt Benckiser Group plc
Johnson & Johnson

MACROECONOMIC INDICATORS

Country Data

APPENDIX

Methodology
Industry associations
Related MarketLine research

LIST OF TABLES

Table 1: Australia OTC pharmaceuticals market value: $ million, 2006–10
Table 2: Australia OTC pharmaceuticals market category segmentation : % share, by value, 2006 - 2010
Table 3: Australia OTC pharmaceuticals market category segmentation : $million, by value, 2006 - 2010
Table 4: Australia OTC pharmaceuticals market geography segmentation, by value, 2010
Table 5: Australia OTC pharmaceuticals market share: % share, by value, 2010
Table 6: Australia OTC pharmaceuticals market distribution: % share, by value, 2010
Table 7: Australia OTC pharmaceuticals market value forecast: $ million, 2010–15
Table 8: Cerebos Pacific Limited: key facts
Table 9: Reckitt Benckiser Group plc: key facts
Table 10: Reckitt Benckiser Group plc: key financials ($)
Table 11: Reckitt Benckiser Group plc: key financials (£)
Table 12: Reckitt Benckiser Group plc: key financial ratios
Table 13: Johnson & Johnson: key facts
Table 14: Johnson & Johnson: key financials ($)
Table 15: Johnson & Johnson: key financial ratios
Table 16: Australia size of population (million), 2006–10
Table 17: Australia gdp (constant 2000 prices, $ billion), 2006–10
Table 18: Australia gdp (current prices, $ billion), 2006–10
Table 19: Australia inflation, 2006–10
Table 20: Australia consumer price index (absolute), 2006–10
Table 21: Australia exchange rate, 2006–10

LIST OF FIGURES

Figure 1: Australia OTC pharmaceuticals market value: $ million, 2006–10
Figure 2: Australia OTC pharmaceuticals market category segmentation : $million, by value, 2006 - 2010
Figure 3: Australia OTC pharmaceuticals market geography segmentation : % share, by value, 2010
Figure 4: Australia OTC pharmaceuticals market share: % share, by value, 2010
Figure 5: Australia OTC pharmaceuticals market distribution: % share, by value, 2010
Figure 6: Australia OTC pharmaceuticals market value forecast: $ million, 2010–15
Figure 7: Forces driving competition in the OTC pharmaceuticals market in Australia, 2010
Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in Australia, 2010
Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in Australia, 2010
Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Australia, 2010
Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Australia, 2010
Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in Australia, 2010
Figure 13: Reckitt Benckiser Group plc: revenues & profitability
Figure 14: Reckitt Benckiser Group plc: assets & liabilities
Figure 15: Johnson & Johnson: revenues & profitability
Figure 16: Johnson & Johnson: assets & liabilities
Skip to top